Fibrin stabilization (factor XIII), fibrin structure and thrombosis.
Factor XIII (FXIII) is a zymogen that is converted into an active transglutaminase (FXIIIa) by the concerted action of thrombin and Ca2+. Its main task is to crosslink alpha-, and gamma-chains of fibrin and alpha2-plasmin inhibitor to fibrin. By this way FXIIIa strengthens fibrin and protects it from the prompt elimination by fibrinolytic system.The changes of FXIII level in thrombotic diseases are hardly explored and there are contradictory results concerning the protective effect of Val34Leu polymorphism against arterial or venous thrombosis. The results suggest that the thrombo-protective effect of Leu34 allele prevails only in certain genetic and/or environmental constellations.
Bereczky
Zsuzsanna
Z
Clinical Research Center and Thrombosis Research Group of the Hungarian Academy of Sciences, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary.
Katona
Eva
E
Muszbek
László
L
D005176:Factor XIII / Q000235:genetics* / Q000378:metabolism*; D005337:Fibrin / Q000378:metabolism*; D006801:Humans; D011110:Polymorphism, Genetic; D013927:Thrombosis / Q000097:blood* / Q000235:genetics*
D005337:Fibrin; D005176:Factor XIII